Patrick Donnelly
Stock Analyst at Citigroup
Total Price Targets
8
Stocks Covered
8
Sectors
Healthcare
Most Recent
Oct 23, 2024
Stocks Covered by Patrick Donnelly
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics Incorporated | $185.00 | $192.76 | -4.0% | 1 | Oct 23, 2024 |
| A | Agilent Technologies, Inc. | $165.00 | $114.72 | +43.8% | 1 | Oct 14, 2024 |
| HOLX | Hologic, Inc. | $85.00 | $76.01 | +11.8% | 1 | Oct 1, 2024 |
| BIO | Bio-Rad Laboratories, Inc. | $400.00 | $254.44 | +57.2% | 1 | Oct 1, 2024 |
| BRKR | Bruker Corporation | $80.00 | $36.66 | +118.2% | 1 | Sep 23, 2024 |
| TMO | Thermo Fisher Scientific Inc. | $620.00 | $469.31 | +32.1% | 1 | Sep 19, 2024 |
| STVN | Stevanato Group S.p.A. | $28.00 | $17.52 | +59.8% | 1 | Aug 7, 2024 |
| RVTY | Revvity, Inc. | $135.00 | $86.76 | +55.6% | 1 | Jul 29, 2024 |
Recent Activity
- Oct 23, 2024— Set$185.00price target onDGX(Quest Diagnostics Incorporated)
- Oct 14, 2024— Set$165.00price target onA(Agilent Technologies, Inc.)
- Oct 1, 2024— Set$85.00price target onHOLX(Hologic, Inc.)
- Oct 1, 2024— Set$400.00price target onBIO(Bio-Rad Laboratories, Inc.)
- Sep 23, 2024— Set$80.00price target onBRKR(Bruker Corporation)
- Sep 19, 2024— Set$620.00price target onTMO(Thermo Fisher Scientific Inc.)
- Aug 7, 2024— Set$28.00price target onSTVN(Stevanato Group S.p.A.)
- Jul 29, 2024— Set$135.00price target onRVTY(Revvity, Inc.)
Frequently Asked Questions
Who is Patrick Donnelly?
Patrick Donnelly is a stock analyst at Citigroup covering 8 stocks primarily in Healthcare. They have issued 8 price targets since Jul 29, 2024.
What stocks does Patrick Donnelly cover?
Patrick Donnelly currently covers 8 stocks, including DGX, A, HOLX, BIO, BRKR.
What is Patrick Donnelly's latest price target?
Patrick Donnelly's most recent price target was $185.00 on DGX (Quest Diagnostics Incorporated), set on Oct 23, 2024.
What is Patrick Donnelly's highest price target?
Patrick Donnelly's highest issued price target is $620.00 on TMO, set on Sep 19, 2024.
More Analysts at Citigroup
Coverage based on publicly published price targets. Not investment advice.